Benzinga | May 18, 2021 07:40AM EDT

Foghorn Therapeutics, Syneos Health Study of FHD-286 in Subjects With Advanced Hematologic Malignancies Posted to Clinical Trials Website; Study is Now Recruiting

https://clinicaltrials.gov/ct2/show/NCT04891757